M.E. Allison & Co., Inc. Eli Lilly & CO Transaction History
M.E. Allison & Co., Inc.
- $90.7 Billion
- Q4 2024
A detailed history of M.E. Allison & Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, M.E. Allison & Co., Inc. holds 1,323 shares of LLY stock, worth $1.07 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
1,323Holding current value
$1.07 Million% of portfolio
1.13%Shares
1 transactions
Others Institutions Holding LLY
# of Institutions
4,073Shares Held
737MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$78.6 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$59.8 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$53.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$41.7 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$27.5 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $771B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...